VRC01LS
Gecertificeerd

VRC01LS

Catalog #: HY-P991246-01
Maat: 1 mg
Droogijs Vereist

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

VRC01LS is a humanized monoclonal antibody inhibitor targeting the CD4-binding site of HIV-1 envelope glycoprotein (Env) . VRC01LS blocks the binding of HIV-1 to host cell CD4 receptor, inhibiting viral entry. VRC01LS is promising for research of HIV-1 infection[1][2].

UNSPSC

12352203

Target

HIV; Virus Protease

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Purity

98.78

Smiles

[VRC01LS]

Molecular Weight

(145.94 kDa)

References & Citations

[1]Happe M, et al. Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection. JCI Insight. 2025 Feb 24;10 (4) :e181496.|[2]Gaudinski MR, et al. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 Jan 24;15 (1) :e1002493.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P991246/VRC01LS-SDS-MedChemExpress.pdf

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 2

Beschrijving

VRC01LS is a humanized monoclonal antibody inhibitor targeting the CD4-binding site of HIV-1 envelope glycoprotein (Env) . VRC01LS blocks the binding of HIV-1 t

Specificaties

ProductnaamVRC01LS
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-P991246-01